EcoDrugPlus

Solute Carrier Family 6 Member 2

Ensembl ID : ENSOTSG00005033202
Gene Symbol: SLC6A2
3 Cross references
197 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSOTSG00005002586
Gene Symbol: SLC6A3
1 Cross references
165 Possible Orthologues:

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSOTSG00005020518
Gene Symbol: SLC6A4A
1 Cross references
195 Possible Orthologues:

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSOTSG00005015583
Gene Symbol: SLC6A4A
1 Cross references
194 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSOTSG00005023108
Gene Symbol: SLC6A9
1 Cross references
202 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSOTSG00005021866
Gene Symbol: SLC6A9
1 Cross references
202 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSOTSG00005039463
Gene Symbol: SLC9A3
3 Cross references
222 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSOTSG00005002440
Gene Symbol: SLC9A3
1 Cross references
222 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSOTSG00005004232
Gene Symbol: SLC9A3
1 Cross references
222 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSOTSG00005012904
Gene Symbol: SSTR1
1 Cross references
151 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSOTSG00005014262
Gene Symbol: SSTR1
3 Cross references
151 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSOTSG00005034753
Gene Symbol: SSTR1
3 Cross references
151 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).